How do you know if a particular medicine is working?

Traditionally, it takes guesswork on the physician’s part and time to find a drug that works for any given patient.

But what if we could leverage digital biomarkers to measure the efficacy of a medication very quickly and course correct as needed?

Rich Carter serves as Chief Digital Officer at Eli Lilly, where he oversees the teams focused on innovation, user-centered design and digital health.

On this episode of The Beat, Rich joins hosts Dr. Jessica Shepherd and Dr. Gautam Gulati to discuss the future of drug development and clinical trials.

Rich describes what digital transformation means in the context of life sciences, explaining how technology can improve drug discovery and accelerate the timeline from discovery to market.

Listen in for examples of the 35 digital biomarkers in development at Lilly and learn how Rich’s team thinks about partnering with both physicians and patients to roll out these new digital resources.

Topics Covered

• 3 elements of Rich’s role at Lilly—innovation, design and digital health
• What digital transformation means in the context of life sciences
• How Lilly Direct is working to simplify the patient experience
• What we do historically in life sciences that doesn’t make sense anymore (given the technology we have today)
• The potential for AI to remove bias in the drug discovery space
• Rich’s insight on accelerating the discovery-to-market process in life sciences
• How Rich’s team uses ‘old data’ to train predictive AI models and why access to data is one of the biggest challenges in life sciences
• Using digital biomarkers to measure the efficacy of a medicine with diverse populations
• How Rich is inspired by the impact his work has on families
• The 35 biomarkers in different stages of development at Lilly and what that process look like
• How Lilly’s internal incubation lab partners with other innovators in the healthcare ecosystem
• Partnering with both patients and physicians to roll out digital resources

Connect with Rich Carter

• Eli Lilly
• Rich on LinkedIn

Connect with Dr. Gautam Gulati & Dr. Jessica Shepherd

• ViVE
• HLTH
• Dr. Shepherd on Twitter
• Dr. Shepherd on LinkedIn
• Dr. Gulati on Twitter
• Dr. Gulati on LinkedIn

Resources

• Lilly Direct